1. Zhang, Jingwan, Zhai, Jianning, Wong, Chi Chun, Ji, Jiafu, Yu, Jun. 2021. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML). In Oncogene, 40, 6641-6652. doi:10.1038/s41388-021-01941-z. https://pubmed.ncbi.nlm.nih.gov/34625711/
2. Crespo, Raquel, Ne, Enrico, Reinders, Julian, Rao, Shringar, Mahmoudi, Tokameh. 2024. PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency. In iScience, 27, 109152. doi:10.1016/j.isci.2024.109152. https://pubmed.ncbi.nlm.nih.gov/38384833/
3. Ye, Buqing, Dai, Zhonghua, Liu, Benyu, Sakaguchi, Nobuo, Fan, Zusen. . Pcid2 inactivates developmental genes in human and mouse embryonic stem cells to sustain their pluripotency by modulation of EID1 stability. In Stem cells (Dayton, Ohio), 32, 623-35. doi:10.1002/stem.1580. https://pubmed.ncbi.nlm.nih.gov/24167073/
4. Nakaya, Teruo, Kuwahara, Kazuhiko, Ohta, Kazutaka, Kondo, Eisaku, Sakaguchi, Nobuo. 2010. Critical role of Pcid2 in B cell survival through the regulation of MAD2 expression. In Journal of immunology (Baltimore, Md. : 1950), 185, 5180-7. doi:10.4049/jimmunol.1002026. https://pubmed.ncbi.nlm.nih.gov/20870947/
5. Gondo, Naomi, Sakai, Yasuhiro, Zhang, Zhenhuan, Rezano, Andri, Kuwahara, Kazuhiko. 2021. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas. In Laboratory investigation; a journal of technical methods and pathology, 101, 1048-1059. doi:10.1038/s41374-021-00613-6. https://pubmed.ncbi.nlm.nih.gov/34031538/